HomeAuthorsPosts by Sam Atkinson

Sam Atkinson

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge in profit for the third quarter ended May 31, 2026. This performance marks a decisive shift from a period of recovery toward a new phase of resilient growth in the...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the country grapples with a growing burden of non-communicable diseases (NCDs), particularly diabetes and chronic kidney disease. Recent estimates show that one-in-six Malaysians has diabetes, while one-in-seven is at risk of chronic...
spot_img

Keep exploring

SGX-LISTED COMPANIES

One Asset Deal Changed Everything For Tianjin Da Ren Tang In Q3 2025

How Tianjin Da Ren Tang's Revenue Fell 35% While Its Profits Soared: 4 Surprising...
SGX-LISTED COMPANIES

Consumable Tools Hit 13-Quarter High In Micro-Mechanics 1QFY2026

The Niche Manufacturer's Playbook: 3 Surprising Strategies for Thriving in Chaos In a world defined...
SGX-LISTED COMPANIES

Operational Gains Shock Analysts In LMIRT’s Strong 3Q 2025

4 Surprising Truths Hidden in a Shopping Mall's Financial Report Introduction: Beyond the "Retail Apocalypse"...
SGX-LISTED COMPANIES

DPU Suffers In Mapletree Industrial Trust’s Q2FY25/26

Mapletree Industrial Trust’s Payouts Dropped. Here Are 4 Surprising Reasons Why That Might Be...
SGX-LISTED COMPANIES

Singapore Paincare Swings To Net Loss In FY2025

5 Surprising Reasons Behind Singapore Paincare's Shocking Swing from Profit to a S$3.7 Million...
SGX-LISTED COMPANIES

Key Milestones Drive Nomura’s Strong Net Income Growth In Q2 2025

Beyond the Billions: 5 Surprising Stories Inside Nomura's Latest Earnings Report Introduction: The Hidden Stories...
SGX-LISTED COMPANIES

Proactive Strategy Delivers Resilient Performance For Mapletree Logistics Trust In Q2 FY25/26

5 Surprising Insights from Mapletree Logistics Trust’s Latest Results Introduction: A Deeper Dive Into the...
SGX-LISTED COMPANIES

Why High Costs Caused Sunrise Holdings To Lose S$2.3M In FY2025

Sunrise Holdings Revenue Grew 1,315% While Its Losses Deepened. Here Are 4 Shocking Details...
SGX-LISTED COMPANIES

How iFAST Reached New Profit And Asset Milestones In Q3 2025

4 Surprising Insights from iFAST's Record-Breaking Quarter iFAST Corp recently announced a record-breaking quarter, with...
SGX-LISTED COMPANIES

Frasers Centrepoint Trust Sees Huge Leasing Momentum In FY25

Beyond the Billions: 4 Surprising Secrets from a Singapore Mall Giant's Latest Report Introduction: The...
SGX-LISTED COMPANIES

Find Out Why ISEC Healthcare’s Strong Q3 2025 Sales Didn’t Translate To Higher Profits

More Sales, Less Profit: 5 Surprising Takeaways from ISEC Healthcare's Latest Financials It’s a fundamental...
SGX-LISTED COMPANIES

What’s Behind MPACT’s Profit Decline in 2Q FY25/26?

4 Surprising Takeaways from MPACT's Latest Financial Results Introduction: Beyond the Balance Sheet Financial press releases...
Load more

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...